IVERIC bio - M&A Summary, Ownership, and Business Overview

Life ScienceCompany

IVERIC bio M&A Summary

IVERIC bio has acquired 1 company of its own.

IVERIC bio has acquired in 1 US state. The Company’s most targeted sectors include life science (100%).

IVERIC bio Ownership

Who owns IVERIC bio?

IVERIC bio is owned by Astellas Pharma. It was acquired on April 30, 2023.

IVERIC bio Business Overview

Where is IVERIC bio headquartered?

IVERIC bio is headquartered in Cranbury, New Jersey.

What is IVERIC bio’s revenue?

IVERIC bio disclosed revenue of 210M USD for 2017 and 51M USD for 2016.

What sector is IVERIC bio in?

IVERIC bio is a life science company.

When was IVERIC bio founded?

IVERIC bio was founded in 2007.

M&A Summary

  • M&A Total Activity1
    • M&A Buy Activity1
  • Total Sectors Invested 1
  • Total Countries Invested 1

IVERIC bio

IVERIC bio, Inc.

1249 South River Road, Suite 107,
Cranbury, New Jersey 08512
United States,
(609) 474-6755
www.ivericbio.com

IVERIC bio is a biopharmaceutical company specializing in the development of novel therapeutics to treat ophthalmic diseases, with a focus on orphan and age-related retinal diseases. IVERIC bio was founded in 2007 and is based in Cranbury, New Jersey.


M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (0.0/yr) # 1 - - - - - 1
Sell (0.0/yr) # - - - - - - 0
  1

Most Recent M&A

Company Date Value Type
Inception 4, Inc. 2018-10-31 - Add-on Acquisition
San Diego, California
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 1 (100%) - - -
Total 1 - - -

By Geo

State/Country Buy Value Sell Value
United States 1 - - -
  California 1 - - -
Total 1 - - -

 Subscribe to unlock this and 209,235
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 202K M&A Transactions
  • 205K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.